Search the Newsreel

Buru Energy (ASX:BRU) Jumps 16.67% as Rafael Gas Strategy Returns to Focus

Brunswick Corp (BC) Stock Earnings Transcripts

Brunswick Corporation Exec Sets Scene for Latest Showcase in NYC

Brunswick's Ryan Gwillim joins Kristen Scholer on NYSE Live to discuss his company any latest showcase in NYC View Comments

Sea Ray parent Brunswick bets on AI navigation and new revenue streams to help stalling boat sales

Old West Investment Management LLC Acquires Shares of 667,103 Bruker Corporation $BRKR

Old West Investment Management LLC has acquired a significant new stake of 667,103 shares in Bruker Corporation (NASDAQ:BRKR), valued at approximately $40.1 million. This makes Bruker its largest portfolio holding, representing 4.3% of its assets and about 0.44% of Bruker's total shares. Bruker recently …

Bruker Corporation (BRKRP) Q2 2026 Earnings: Preferred Series A Tracks Strong EPS Beat as Shares Slip - Pretax Income Report

Brunswick Corporation (BC) Gains 1.31% as Marine Sector Sentiment Improves - High Yield Stocks

Bruker declares $0.05 quarterly dividend for common shareholders

Bruker Corporation (NASDAQ:BRKR) has declared a quarterly cash dividend of $0.05 per share, payable on October 7, 2026. This dividend results in a 0.35% yield and comes as the stock has seen a 73% gain over the past year. Despite strong shareholder yield, the …

Bruker (BRKR) Is Up 13.0% After Cutting 2026 Outlook And Expanding AI Lab Tie-Up With Atinary

Celebrus Technologies Updates Voting Rights After Share Buyback

Bruker Corp Executive Mark Munch Reports Share Withholding to Cover RSU Tax Obligations

Mark Munch, Executive Vice President and President of Bruker Nano Inc., disposed of 1,619 shares of Bruker Corp common stock on August 11, 2026, to cover tax withholding obligations associated with the vesting of restricted stock units. The shares, valued at $57.02 each, were …

Celebrus Technologies Updates Share Capital After Treasury Share Buyback

Brunswick (BC) Earnings And Buyback Put Valuation Back In Focus

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Bruker Corporation announced an expanded strategic collaboration with Atinary Technologies Inc., a pioneer in Self-Driving Labs technologies and AI-driven R&D, which also includes a minority investment by Bruker. The collaboration aims to integrate Atinary's SDLabs platform with Chemspeed automation and Bruker instruments to create …

Bruker (BRKR) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Director of Investor Relations - Joe KostkaPresident and Chief Executive Officer - Frank LaukienExecutive Vice President and Chief Financial Officer - Gerald Herman TAKEAWAYS Revenue -- $838.5 million …

Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance

J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $60

J.P. Morgan has reiterated its Buy rating on Bruker Corp (BRKR.US) but has revised its target price downwards to $60. This adjustment reflects J.P. Morgan's updated valuation for the company while maintaining a positive outlook on its stock.

Bruker takes majority stake in organ-on-a-chip firm MIMETAS

Bruker Corporation has acquired a majority stake in MIMETAS B.V., a company specializing in organ-on-a-chip platforms and human tissue models for drug discovery. This investment will allow Bruker to integrate MIMETAS' OrganoPlate platform with its existing technologies, expanding its offerings in Microphysiological Systems. MIMETAS …

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

MIMETAS' unique organ-on-a-chip and human tissue models complement Bruker's multiomics, NMR, spatial biology and preclinical imaging solutions LEIDEN, The Netherlands, August 10, 2026--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue …

Why Bruker (BRKR) Is Down 20.3% After Q2 Impairment-Driven Loss And Soft 2026 Guidance

Amundi Increases Stock Position in Bruker Corporation $BRKR

Amundi increased its stake in Bruker Corporation (NASDAQ:BRKR) by 244.2% in the first quarter, now holding 62,611 shares valued at $2.26 million. Despite the company beating EPS estimates for Q2 2026 with $0.49 per share, its revenue of $838.5 million missed analyst expectations, raising …

Brunswick Corporation $BC Shares Purchased by California State Teachers Retirement System

Bruker Corp (BRKR): FMR LLC and Abigail Johnson report 15% ownership

FMR LLC and Abigail P. Johnson have reported a 15.0% beneficial ownership stake in Bruker Corp (BRKR) common stock, as detailed in a Schedule 13G/A SEC filing. FMR LLC beneficially owns 23,296,465.55 shares, with sole voting power over 17,974,598.38 shares and sole dispositive power …

Does Brunswick’s EPS Jump And Buybacks Shift The Bull Case For BC?

J.P. Morgan Maintains Brunswick Corp(BC.US) With Hold Rating, Cuts Target Price to $80

J.P. Morgan has reiterated its Hold rating for Brunswick Corp (BC.US) but has lowered its price target to $80. This adjustment reflects the firm's updated valuation for the company.

Bruker Corp (BRKR) Stock Up 4.3% and Still Undervalued -- GF Sco

Bruker Corp (BRKR) shares rose 4.3% to $52.47, trading below its GF Value™ of $62.94, suggesting it is undervalued despite being currently unprofitable and cash-flow negative. The company has a strong GF Score™ of 85/100, driven by good profitability and momentum, though its financial …

Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $70

Guggenheim has reiterated its Buy rating for Bruker Corp (BRKR.US), maintaining a target price of $70. This indicates a continued positive outlook from the firm regarding Bruker's stock performance and value.

Stifel raises Bruker stock price target to $50 on semi strength

Is Bruker (BRKR) Fairly Valued After Its 52 Week High?

Bruker (BRKR) stock has seen significant growth over the past year, reaching a 52-week high, yet analysis suggests it remains undervalued. Discounted Cash Flow (DCF) models indicate the stock trades at approximately a 41.1% discount to its intrinsic value, while its Price/Sales (P/S) multiple …

Polaris, Peers Delivered Q2 Beats And Raises Amid Demanding Setups, Morgan Stanley Says

Polaris (PII) and its peers in the powersports systems space, Harley-Davidson (HOG) and Brunswick (B PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have …

Bruker: Q2 Earnings Snapshot

Bruker Corp. reported a second-quarter loss of $52 million, or 41 cents per share, which was a reversal from a profit in the same period last year. Despite the loss, adjusted earnings of 49 cents per share surpassed Wall Street expectations. The scientific equipment …

Bruker (BRKR) Is Down 20.0% After Goodwill Impairment-Fueled Q2 Loss Despite Higher Sales

Bruker Corporation's Q2 2026 results, released on August 4, 2026, showed sales rising to US$838.5 million from US$797.4 million year over year, but a goodwill and intangible asset impairment charge of US$134.9 million and other items drove a net loss of US$52 million versus …

Bruker Corporation (NASDAQ: BRKR) hit by $134.9M goodwill charge in Q2